TransMedics (TMDX) Non-Current Deffered Revenue (2018 - 2021)

TransMedics' Non-Current Deffered Revenue history runs 4 years deep, the most recent figure standing at $1.6 million for Q3 2021.

• In Q3 2021, Non-Current Deffered Revenue changed 0.43% year-over-year to $1.6 million; the TTM figure through Sep 2021 stood at $1.6 million (changed 0.43% YoY), while the FY2020 annual figure was $1.6 million, up 311.05% from the prior year.
• Non-Current Deffered Revenue for Q3 2021 stood at $1.6 million, up from $1.5 million in the prior quarter.
• The five-year high for Non-Current Deffered Revenue was $1.6 million in Q3 2020, with the low at $389000.0 in Q4 2019.
• The 4-year median for Non-Current Deffered Revenue is $932000.0 (2020), against an average of $1.1 million.
• The sharpest annual moves came in 2019 and 2020: Non-Current Deffered Revenue slumped 48.75% in 2019, then soared 311.05% in 2020.
• TransMedics' Non-Current Deffered Revenue stood at $759000.0 in 2018, then plunged by 48.75% to $389000.0 in 2019, then jumped by 311.05% to $1.6 million in 2020, then grew by 1.06% to $1.6 million in 2021.
• Business Quant data shows TMDX's Non-Current Deffered Revenue at $1.6 million in Q3 2021, $1.5 million in Q2 2021, and $1.6 million in Q1 2021.